180 Life Sciences Corporation (ATNF)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -2.5 | 0.211 | 0.884 | -0.139 | -31.995 | -34.376 | -94.037 | -160.063 |
Return on Equity (%) | -27.273 | 4.938 | 20.82 | -1.82 | -61.688 | -58.394 | -152.865 | -355.474 |
Return on Invested Capital (%) | -3.704 | 0.967 | 1.747 | 27.07 | -34.69 | -70.122 | -91.763 | -236.169 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.008 | 1.19 | 27.779 | 1.199 | -0.626 | 0.011 | 0.166 | -0.234 |
Earnings Per Share | -0.001 | 0.03 | 0.254 | -0.02 | -0.786 | -0.597 | -10.33 | -2.666 |
Cash Per Share | 0.023 | 0.102 | 0.066 | 0.123 | 0.152 | 0.242 | 1.859 | 0.264 |
Working Capital Per Share | 0.056 | 0.062 | -0.067 | -0.562 | -1.257 | -0.25 | 0.872 | -0.19 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.001 | 0.076 | 0.355 | 0.037 | -0.788 | -0.598 | -10.581 | -2.98 |
EBITDA Per Share | -0.001 | 0.076 | 0.355 | 0.037 | -0.788 | -0.598 | -10.581 | -2.98 |
Free Cash Flow Per Share | -0.001 | 0.03 | 0.254 | -0.02 | -0.786 | -0.597 | -10.359 | -2.68 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 2,88M | 4,2M | 4,1M | 4,46M | 13,85M | 34,04M | 3,75M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 3,75M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,99M |
Ratio cours/bénéfice | -0,15 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,49 |
Ratio prix/valeur comptable | -23,01 |
Rendement de dividende | - |
Actions en circulation | 1,98M |
Volume moyen (1 semaine) | 268,19k |
Volume moyen (1 mois) | 1,18M |
Variation sur 52 semaines | -62,79% |
Plus haut sur 52 semaines | 17,75 |
Plus bas sur 52 semaines | 1,18 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales